Launch your Graphy
There are no items in your cart
Add More
Add More
| Item Details | Price | ||
|---|---|---|---|
Mutation Signatures and Genome Protection
access_time 2026-01-02T11:43:13.638Z face Shruti Joshi
Mutation Signatures and Genome Protection SwaLife Biotech 2.1.26 Applications of Whole-Exome Sequencing (WES) in Chemoprevention Trials Cancer does not emerge overnight. Long before clinical detection, genomes accumulate mutations driven by carcinogen exposure, oxidative stress, chronic inflammation...
Project-Based Program: Moringa Against Alzheimer’s
access_time 2026-01-02T11:39:00.928Z face Shruti Joshi
Project-Based Program: Moringa Against Alzheimer’s SSTSI 2.1.26 An AI-Driven, Systems Neuroscience Exploration of Cognitive Protection Alzheimer’s disease is no longer viewed as a single-pathway disorder. It is a multi-dimensional neurodegenerative process involving chronic neuroinflammation, oxidat...
How AI Assists in Predictive Analysis
access_time 2025-12-31T12:13:03.367Z face Shruti Joshi
How AI Assists in Predictive Analysis MolecuNex AI 31.12.25 Cancer is no longer viewed as a single disease with a single trajectory. It is a dynamic, evolving system shaped by genetics, environment, metabolism, immunity, and time. In this landscape, predictive analysis powered by AI is transforming ...
Formulating Herbal Products for Chronic Diseases Using Multi-Studio Insights
access_time 2025-12-31T12:11:14.628Z face Shruti Joshi
Formulating Herbal Products for Chronic Diseases Using Multi-Studio Insights SwaLife Consultancy 31.12.25 From Complexity to Clinically Aligned Innovation Chronic diseases do not follow linear biology. Conditions such as diabetes, PCOS, cancer, and arthritis unfold through years of molecular disrupt...
Clonal Evolution and Genomic Stability as Endpoints of Chemoprevention
access_time 2025-12-31T12:08:15.58Z face Shruti Joshi
Clonal Evolution and Genomic Stability as Endpoints of Chemoprevention SwaLife Biotech 31.12.25 Evidence from Whole-Exome Sequencing Studies Cancer prevention has traditionally been measured by a single, blunt outcome: whether cancer eventually appears or not. Yet advances in cancer genomics particu...